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Sampler programming
Seven portable automated samplers (6712 Full-Size Portable Sampler, Teledyne Isco, Lincoln, NE, USA) were programmed based on three-week average hourly-daily flow rate data.
24 subsamples were merged to get about 2.5 liters of daily flow-weighted composite sample. Samplers were programmed to draw 20 ml incremental samples for a given hour.
Volume of sample collected at hour t = where, Q t = measured flowrate at t, Q avg = average daily flowrate over the course of three weeks Figure S1 . Flow diagram showing treatment processes for wastewater and sludge in the investigated activated sludge treatment plant. Numbers indicate the sampling locations used. At locations 1, 2, 3, 4, 5, 8, and 9 flow-weighted, 24-hour composite samples were collected using automated samplers. At locations 6 and 7, grab samples were collected. The boxes outlined in blue and brown color represent, respectively, the control volumes used to conduct mass balances on the wastewater treatment train and the engineered wetland located immediately downstream. 
S4
Isotope Dilution, Standard Addition, and Calibration
For imidacloprid, acetamiprid and clothianidin, the isotope dilution technique was utilized to determine losses during extraction and to compensate for potential ion suppression during LC-MS/MS detection. Deuterated isotopes (imidacloprid-d 4 , acetamiprid-d 3 and clothianidin-d 3 ) were spiked before extraction at pre-determined, anticipated levels. A trideuterated isomer of acetamiprid (d 3 ) was also used to enable quantification of acetamiprid-Ndesmethyl. For imidacloprid, acetamiprid, acetamiprid-N-desmethyl, and clothianidin, calibration standards were prepared in clean matrix (water, methanol and formic acid mixtures (80/20/0.1, v/v/v)).
For thiacloprid, thiamethoxam, and dinotefuran, the method of standard addition was utilized to compensate for ion suppression during the LC-MS/MS detection.
1 Matrix spike and matrix spike duplicates were performed in each sample matrix to determine the overall recovery of the analytes. Quantification was performed using 8-point, linear calibration curves for each analyte in the specific concentration range of interest, and calibration curves with a coefficient of determination R 2 > 0.99 were considered satisfactory.
Quality Assurance and Quality Control
Field, trip and instrument blanks, consisting of ultrapure reagent grade water placed in sampling containers, were analyzed; any resultant signals were subtracted from those obtained for study samples within the same analytical batch. For all analytes, field blank chromatograms showed no to <10% of the signal intensity obtained in chromatograms for actual samples.
Precision was assessed by analyzing samples and duplicates, and calculating the corresponding relative percentage difference (RPD) value using the following equation:
where, C sample and C duplicate are the detected concentrations in the original sample and its duplicate, respectively. 
Determination of Method Detection Limits and Reporting Limits.
Method detection limits (MDLs) were determined according to the EPA guidelines described in 40 CFR 136, Appendix B. Data are reported when peak areas were above the lowest concentration calibration standard prepared in clean matrix, when the peak had a signal-to-noise ratio of >3, and when the calculated concentration was equivalent or higher than the established MDL. Theoretical MDLs determined with this approach were verified by spiking authentic matrices and adjusting the MDL values upward as needed to account for matrix effects. In rare cases where blanks of analytical batches showed signals for analytes, the MDL was defined as 10 times the level of background detected in the blank. MDLs were used as reporting limits. The limit of quantitation (LOQ), was defined as 3 times the practical MDL. Data equal to or exceeding the reported LOQ values are considered more robust than those above the MDL but below the respective LOQ.
Method Detection Limit Calculation. The method detection limit (MDL) (the minimum concentration of a substance that can be measured and reported with 99% confidence that the analyte concentration is greater than zero and is determined from analysis of a sample in a given matrix containing the analyte) was determined by USEPA method. Seven replicate (n) spikes were prepared at an appropriately low concentration (about 1 to 5 times expected MDL) and processed through the entire analytical method. Following equation was used to determine MDL, MDL = ‫ݏ‬ × ‫ݐ‬ (୬ିଵ,ଵି ୀ .ଽଽ) (SE 2) where, s = standard deviation of measured concentrations of n spike determinations, n = number of replicate spike determinations = 7, α = level of significance = 0.01, t = student's t value at n-1 degrees of freedom and 1-α confidence level = 3.14.
Determination of Absolute and Relative Analyte Recovery. Absolute recovery of analytes, expressed as a percentage, was determined by fortifying and analyzing representative environmental samples (influent, effluent, sludge) with authentic standards to obtain matrix spike and matrix spike duplicate information. For compounds for which isotope-labeled standards were available, relative recovery rates were calculated by adjusting the determined absolute recovery rate for non-ideal (not 100%) recovery of the respective labeled surrogate standard. In accordance with the isotope dilution method, only data reported for analytes featuring labeled surrogate standards were reported as normalized concentrations. All other data represent absolute concentrations determined.
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Statistical Data Analysis
In this study, the error value in the average daily concentration was calculated as the standard deviation of measured concentrations obtained for daily samples and their respective replicates over the 5-day sampling period. The error value for the total mass during the 5-day sampling period was calculated using the maximum and minimum values obtained from two experimental replicates.
Kathon CG/ICP
In this study 600 mg/L of Kathon CG/ICP (purchased from Sigma-Aldrich Corp., St.
Louis, MO, USA) preservative was added to wastewater to disinfect the samples. Kathon CG/ICP contains 1.15% 5-chloro-2-methyl-4-isothiazolin-3-one and 0.35% 2-methyl-4-isothiazolin-3-one as active ingredients. Mass balances for primary, secondary, and disinfection treatment were calculated using the following equations, respectively: was obtained as shown in Figure S2 . Figure S3 . Mass and concentrations of imidacloprid and acetamiprid in engineered wetland streams, implying persistence to treatment.
